# Mid-Atlantic BioTherapeutics, Inc. — Form D

Mid-Atlantic BioTherapeutics, Inc. of DOYLESTOWN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2024-09-30. The offering totals $5.0M. Industry: Biotechnology.

## Offering

- Filed: 2024-09-30
- Form: D
- Accession: 0001096906-24-001930
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $5.0M
- Remaining: $5.0M
- Minimum investment: $50K
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-525424

## Issuer

- Name: Mid-Atlantic BioTherapeutics, Inc.
- CIK: 0001755678
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Phone: 215-266-2301

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Julian Chick | Director | Doylestown, PA |
| Jean Pierre Gagnon | Director | Doylestown, PA |
| Michael Goldblatt | Director | Doylestown, PA |
| David Horn | Director | Doylestown, PA |
| David Jobes | Director | Doylestown, PA |
| Andrew Katz | Director | Nashville, TN |
| David Horn | Executive Officer | Doylestown, PA |
| David Jobes | Executive Officer | Doylestown, PA |
| Jean Pierre Gagnon | Executive Officer | Doylestown, PA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2018-10-11](https://search.stillhousedata.com/formd/0001445866-18-001101) | D | $10.0M | $875K |

## More

- [CIK 1755678 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1755678&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001096906-24-001930.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.